The new Vanquish Analytical Purification LC system combines the separation power of analytical LC with precise fractionation to generate high purity products or for the isolation of contaminants. Additionally, with the introduction of the new integrated Vanquish Fraction Collector, a wide range of applications are covered, providing all users with purification accuracy across their entire analytical workflow.
Biopharmaceutical labs can now fractionate with precision with high recovery and low transfer, with additional automation features that will allow researchers to focus on achieving success in their process results instead of manipulating the tool. “We have two Vanquish Fraction Collectors and are running them 24/7 right now. Whatever the size of the fraction, it is fractionated and then reanalyzed. The team is thrilled and these fraction collectors work robustly and error-free,” said Dr. Alexander Schwenger, Senior Manager of Analytical Development for CureVac AG, Germany.
“Biopharmaceutical companies working at the forefront of new drug development need detailed characterization of impurities. The superior user experience and separation performance of our award-winning Vanquish LC product line, with the addition of the new Vanquish Fraction Collector, allows researchers to isolate and purify compounds right after their analytical separation,” said Kent. Davidson, vice president and general manager. , High Performance Chromatography Solutions, Thermo Fisher Scientific. “With our wide range of high-quality chromatography consumables, our customers can be confident that sample integrity will be maintained throughout their analytical workflow. Our products can dramatically accelerate science to provide the patient with life-saving new medicines. »